Reproductive · PANCE / PANRE

Intrauterine Growth Restriction (IUGR)

Fetal growth below the 10th percentile for gestational age due to a pathologic process.

Also known as: IUGR, FGR, fetal growth restriction, small for gestational age, SGA

Overview

Fetal growth restriction (now the preferred term, FGR) is defined by ACOG/SMFM as estimated fetal weight or abdominal circumference below the 10th percentile for gestational age. SGA refers to a constitutionally small but otherwise healthy fetus; IUGR/FGR implies a pathologic process limiting growth.

Epidemiology

Affects 3-10% of pregnancies. Strongly associated with stillbirth, perinatal morbidity, and long-term cardiometabolic and neurodevelopmental disease (Barker hypothesis).

Try two board-style Intrauterine Growth Restriction questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1ReproductiveMedium
A 29-year-old woman at 33 weeks of gestation with chronic hypertension presents for a routine visit. Her fundal height measures 28 cm, 5 cm behind that expected for dates confirmed by a first-trimester crown-rump length. Maternal weight gain has been minimal. Ultrasound shows an estimated fetal weight at the 5th percentile with a disproportionately small abdominal circumference relative to the head, an amniotic fluid index of 4 cm, and an umbilical artery Doppler with elevated systolic-to-diastolic ratio. Serial scans confirm a declining growth velocity. Which of the following is the most likely diagnosis?
  • AConstitutionally small fetus, SGA
  • BPreterm prelabor membrane rupture
  • CFetal growth restriction (FGR)
  • DFetal urinary tract obstruction
Reveal answer & full explanation
Correct answer: C — Fetal growth restriction (FGR)
  • AConstitutionally small fetus, SGA
  • BPreterm prelabor membrane rupture
  • CFetal growth restriction (FGR)
  • DFetal urinary tract obstruction

Why Fetal growth restriction (FGR) is correct

  • An estimated fetal weight below the 10th percentile (here the 5th) combined with abnormal umbilical artery Doppler and declining growth velocity meets the Delphi/ACOG-SMFM criteria for FGR, a pathologic process rather than a constitutionally small fetus.
  • The asymmetric pattern (head sparing with a disproportionately small abdomen), low amniotic fluid, a maternal risk factor (chronic hypertension), and elevated Doppler resistance all point to uteroplacental insufficiency.
  • Fundal height lagging >=3 cm behind an accurately dated gestation is the classic screening trigger for FGR.

Why the others are wrong

  • Constitutionally small fetus, SGA — a small but healthy fetus shows normal growth velocity on serial scans and normal Doppler studies with no risk factors; this fetus has abnormal Dopplers and falling velocity.
  • Preterm prelabor membrane rupture — ruptured membranes lower the amniotic fluid index but do not restrict growth, and rupture would not produce an estimated fetal weight at the 5th percentile with a disproportionately small abdominal circumference and elevated umbilical artery resistance.
  • Fetal urinary tract obstruction — obstructive uropathy reduces fetal urine output and can cause oligohydramnios, but it produces a distended bladder or hydronephrosis on ultrasound rather than a head-sparing growth lag with abnormal Doppler, and it does not explain the declining growth velocity in a mother with chronic hypertension.
Question 2ReproductiveMedium
A 29-year-old woman at 30 weeks' gestation, G2P1, is seen for routine prenatal care. Her pregnancy is complicated by chronic hypertension managed with labetalol. Fundal height measures 26 cm, lagging behind prior visits. Dating was confirmed by first-trimester crown-rump length. Ultrasound biometry shows an estimated fetal weight at the 6th percentile with a disproportionately small abdominal circumference; the amniotic fluid index is normal. Which of the following is the most appropriate next diagnostic test?
  • AMaternal serum TORCH antibody panel
  • BUmbilical artery Doppler imaging
  • CAmniocentesis for fetal karyotyping
  • DRepeat growth ultrasound in 4 weeks
Reveal answer & full explanation
Correct answer: B — Umbilical artery Doppler imaging
  • AMaternal serum TORCH antibody panel
  • BUmbilical artery Doppler imaging
  • CAmniocentesis for fetal karyotyping
  • DRepeat growth ultrasound in 4 weeks

Why Umbilical artery Doppler imaging is correct

  • Once fetal growth restriction (EFW <10th percentile) is identified, umbilical artery Doppler velocimetry is the cornerstone of surveillance and the next study; per ACOG/SMFM it is the only intervention shown to improve outcomes in FGR.
  • It distinguishes pathologic placental insufficiency from a constitutionally small fetus and stratifies delivery timing: increased resistance, absent end-diastolic flow (deliver ~34 wk), or reversed end-diastolic flow (deliver ~30 wk).
  • This asymmetric (head-sparing) pattern with maternal chronic hypertension strongly suggests uteroplacental insufficiency, making Doppler assessment essential now.

Why the others are wrong

  • Maternal serum TORCH antibody panel: appropriate for early-onset, symmetric FGR or when anomalies/infection are suspected; this is late-onset, asymmetric, with a clear placental cause, so TORCH testing is low-yield.
  • Amniocentesis for fetal karyotyping: aneuploidy testing is reserved for symmetric, early FGR or FGR with structural anomalies; asymmetric growth from placental insufficiency does not warrant invasive testing here.
  • Repeat growth ultrasound in 4 weeks: growth scans are repeated every 2-4 weeks, but deferring assessment without Doppler in a fetus with confirmed FGR and a hypertensive mother delays detection of fetal compromise.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Intrauterine Growth Restriction (IUGR) outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Maternal: hypertensive disorders (chronic HTN, preeclampsia), pregestational diabetes with vasculopathy, autoimmune (APS, SLE), severe anemia, malnutrition, low pre-pregnancy BMI, cyanotic cardiac disease
  • Behavioral: smoking, alcohol, cocaine, opioid use
  • Placental: placental insufficiency, abruption, infarction, single umbilical artery, velamentous insertion
  • Fetal: aneuploidy (trisomy 13, 18, 21, Turner), congenital malformation, multiple gestation, congenital infection (TORCH — toxoplasmosis, CMV, rubella, syphilis, varicella)

Pathophysiology

Symmetric IUGR (proportional reduction of head and body) typically reflects an early-pregnancy insult — chromosomal abnormality or infection. Asymmetric IUGR (head sparing, with disproportionately small abdomen) reflects later-pregnancy uteroplacental insufficiency, with preferential blood flow to brain at the expense of the liver and subcutaneous tissue.

Clinical presentation

Symptoms

  • Often asymptomatic; detected on screening
  • Decreased fetal movement may indicate fetal compromise

Signs / physical exam

  • Fundal height lagging >=3 cm behind gestational age
  • Low maternal weight gain
  • Findings of associated maternal disease (e.g., hypertension)

Differential diagnosis

  • Constitutionally small (SGA) — Normal growth velocity on serial scans, normal Doppler studies, no risk factors; family history of small but healthy infants
  • Inaccurate dating — LMP unreliable; recheck with first-trimester crown-rump length (most accurate)
  • Oligohydramnios alone — Low AFI without growth lag — consider PROM, urinary tract anomaly

Diagnostic workup

Diagnostic criteria

Delphi consensus: EFW or AC <3rd percentile alone, OR EFW <10th percentile combined with abnormal Doppler indices or low growth velocity.

Labs

  • Targeted maternal evaluation: CMP, urine protein/creatinine ratio (preeclampsia), antiphospholipid antibodies if recurrent
  • TORCH serologies if early-onset, symmetric, or with anomalies
  • Aneuploidy screening / diagnostic testing per indication (cell-free DNA, amniocentesis, microarray)

Imaging

  • Ultrasound biometry: biparietal diameter, head circumference, abdominal circumference, femur length — EFW <10th percentile
  • Amniotic fluid index or single deepest pocket
  • Umbilical artery Doppler velocimetry — cornerstone of surveillance in FGR; assess for increased resistance, absent end-diastolic flow (AEDF), or reversed end-diastolic flow (REDF)
  • Middle cerebral artery (MCA) Doppler and ductus venosus Doppler in advanced or early-onset disease
  • Detailed anatomy scan to evaluate for structural anomalies

Diagnostic algorithm

PatternTiming of InsultTypical EtiologyHead:Abdomen Ratio
SymmetricEarly (1st-early 2nd trimester)Aneuploidy, TORCH infection, teratogenNormal (proportional)
AsymmetricLate (late 2nd-3rd trimester)Placental insufficiency, maternal HTN/PECIncreased (head sparing)
Symmetric vs asymmetric IUGR patterns.

Treatment

First-line

  • Identify and treat reversible causes (smoking cessation, BP control, anticoagulation for APS)
  • Antepartum surveillance: weekly to twice-weekly NSTs and/or BPPs, growth ultrasound every 2-4 weeks, serial umbilical artery Dopplers
  • Antenatal corticosteroids if delivery anticipated 24 0/7 to 33 6/7 wk (consider 34 0/7 to 36 6/7 wk per ACOG)
  • Magnesium sulfate for neuroprotection if delivery <32 wk

Delivery timing (SMFM/ACOG)

  • Isolated FGR with normal Dopplers: 36 0/7 to 37 6/7 wk
  • FGR with comorbid condition or oligohydramnios: 34 0/7 to 37 6/7 wk
  • FGR with absent end-diastolic flow: 34 0/7 wk
  • FGR with reversed end-diastolic flow: 30 0/7 wk
  • Any FGR with abnormal BPP or fetal compromise: deliver

Second-line / adjunct

  • Low-dose aspirin (81 mg daily, started ideally <16 wk) for women at high risk of preeclampsia/placental insufficiency
  • Mode of delivery individualized — cesarean preferred for REDF or non-reassuring monitoring; vaginal delivery acceptable in many cases with continuous monitoring

Complications

  • Stillbirth (risk increases with severity and abnormal Dopplers)
  • Neonatal hypoxia, meconium aspiration, hypoglycemia, hypothermia, polycythemia, hypocalcemia
  • Long-term: neurodevelopmental impairment, hypertension, insulin resistance, cardiovascular disease (DOHaD/Barker hypothesis)

PANCE pearls

  • Absent or reversed end-diastolic flow on umbilical artery Doppler are markers of severe placental insufficiency requiring escalation of care and consideration of delivery.
  • Symmetric IUGR raises concern for early insult — order TORCH and consider aneuploidy testing.
  • Always re-verify dating before diagnosing IUGR — first-trimester ultrasound is the gold standard.
  • Aspirin 81 mg from 12-16 wk reduces preeclampsia and may reduce FGR in high-risk patients (USPSTF Grade A).
  • FGR is not the same as SGA — about 70% of fetuses with EFW <10th percentile are constitutionally small and healthy.

References

  • ACOG PB 227 — ACOG Practice Bulletin 227: Fetal Growth Restriction (Obstet Gynecol 2021)
  • SMFM Consult #52 — SMFM Consult Series #52: Diagnosis and Management of FGR (Am J Obstet Gynecol 2020)
  • USPSTF 2021 — USPSTF Grade A: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality
  • TRUFFLE — Lees et al., Lancet 2015 — Ductus venosus Doppler vs CTG-guided delivery timing in early FGR

Practice Reproductive questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.